Next is Now...
The Department of Autism Research at ANTIBIOSTRESS CLINICS is developing a structured portfolio of 20 scientific manuscripts dedicated to the FIAP® ecosystem in autism.
This publication program is designed to establish a rigorous translational foundation for biologically informed, developmentally sensitive, clinically interpretable, and precision-oriented autism research.
The 20-manuscript roadmap progresses from foundational conceptual models to mechanistic constructs, digital architecture, translational profiles, pilot-study design, ethical foundations, and a final integrative vision of therapeutic equity in autism.
The FIAP® publication roadmap aims to address one of the central challenges in autism research: how to translate heterogeneity into clinically meaningful and individualized care pathways.
Autism spectrum disorder is characterized by substantial variability in biological burden, adaptive reserve, therapeutic engagement, developmental timing, neuroplastic potential, intervention responsiveness, and contextual accessibility.
The FIAP® ecosystem is being developed to organize this complexity into interpretable constructs and translational profiles that may support future research, validation studies, pilot implementation, and precision-care planning.
This first block establishes the conceptual foundation of the FIAP® ecosystem. It defines the major constructs, theoretical rationale, and programmatic direction of the Department’s precision autism research model.
This manuscript introduces the overall FIAP® Framework as an integrative model for translational stratification and precision care in autism. It positions FIAP® as a construct-based ecosystem linking biological burden, therapeutic engagement, adaptive developmental timing, energetic capacity, neuroplasticity, and future digital implementation.
This manuscript presents the Therapeutic Engagement Index — TEI as a translational construct for understanding heterogeneity in intervention responsiveness in autism. It conceptualizes therapeutic engagement as a multidimensional process influenced by biological regulation, developmental readiness, contextual fit, relational accessibility, and intervention demands.
This manuscript develops the Biological Burden Index — BBI as a multidomain construct for conceptualizing cumulative biological load in autism. It focuses on how immune, inflammatory, oxidative, metabolic, autonomic, gastrointestinal, sleep-related, and stress-regulation dimensions may shape developmental regulation and intervention accessibility.
This manuscript outlines the programmatic roadmap of the FIAP® ecosystem, moving from conceptual development to construct operationalization, translational stratification, validation, pilot studies, digital implementation, and precision-care translation.
This manuscript introduces the adaptive neurodevelopmental window concept as an operational basis for timing-sensitive intervention in autism. It examines how developmental readiness, biological state, adaptive reserve, and therapeutic accessibility may influence when intervention is most accessible and potentially effective.
This second block develops the mechanistic and translational center of the FIAP® ecosystem. It examines relationships among BBI, TEI, energetic capacity, adaptive developmental windows, biomarker architecture, and pilot-study design.
This manuscript examines the relationship between biological burden and therapeutic engagement. It proposes that multidomain biological load may influence engagement accessibility, intervention tolerance, regulation, fatigue, and responsiveness.
This manuscript defines energetic capacity as a translational construct linking biological burden, adaptive reserve, intervention tolerance, and neuroplastic potential. It focuses on how energy availability, resilience, fatigue, and biological reserve may influence the capacity to engage in developmental learning.
This manuscript further develops the concept of adaptive neurodevelopmental windows in autism. It examines developmental timing as a dynamic process shaped by biological burden, neuroplastic readiness, environmental stability, therapeutic engagement, and individualized intervention fit.
This manuscript proposes a biomarker architecture for FIAP®-based stratification. It explores how immune, metabolic, oxidative, autonomic, sleep, gastrointestinal, neurophysiological, developmental, and therapeutic-process markers may be organized into clinically interpretable profiles.
This manuscript translates the FIAP® conceptual ecosystem into a pilot-study design. It focuses on feasibility, measurement strategy, construct operationalization, participant stratification, longitudinal monitoring, and preliminary validation.
This third block focuses on the digital endpoint of the FIAP® ecosystem. It presents FIAP®-Digital as a clinician-guided, interpretable, AI-assisted architecture for future translational stratification and precision-care support.
This manuscript presents FIAP®-Digital as a staged roadmap from construct validation to AI-assisted translational stratification and precision care. It emphasizes clinician-guided interpretation, longitudinal updating, ethical responsibility, and future digital implementation.
This manuscript focuses on the architecture of FIAP®-Digital. It proposes a multimodal AI-assisted system designed to integrate biological, physiological, developmental, contextual, and therapeutic-process data into FIAP® construct estimates and translational profiles.
This final block expands the theoretical and clinical depth of the FIAP® ecosystem. It clarifies construct boundaries, profile taxonomy, therapeutic accessibility, nonresponse, developmental systems theory, ethics, and therapeutic equity.
This manuscript defines neuroplastic capacity as a distinct FIAP® construct. It examines how biological state, developmental timing, engagement accessibility, environmental support, and therapeutic fit may influence the potential for adaptive developmental change.
This manuscript clarifies the conceptual boundaries between energetic capacity, neuroplastic capacity, and therapeutic engagement. It aims to prevent construct overlap and strengthen the theoretical precision of the FIAP® ecosystem.
This manuscript proposes a taxonomy of FIAP® translational profiles, including burden-dominant, reserve-constrained, timing-sensitive, engagement-vulnerable, neuroplasticity-limited, and mixed multidomain profiles.
This manuscript reframes therapeutic accessibility as a core outcome domain in autism research and care. It emphasizes not only whether an intervention is delivered, but whether it is biologically, developmentally, emotionally, relationally, and contextually accessible to the individual.
This manuscript challenges the traditional concept of treatment nonresponse. It proposes that many cases of apparent nonresponse may reflect accessibility failure rather than intrinsic treatment failure, emphasizing burden, reserve, timing, engagement, and contextual fit.
This manuscript proposes a developmental systems theory of intervention responsiveness. It conceptualizes intervention response as an emergent property of interactions among biological state, developmental timing, environment, therapeutic process, adaptive reserve, and neuroplastic capacity.
This manuscript examines the ethical foundations of FIAP®-based precision stratification. It addresses data responsibility, algorithmic interpretability, clinician oversight, equity, consent, stigma prevention, and the responsible translation of construct-based profiles into care planning.
This final synthesis manuscript integrates the full FIAP® ecosystem. It presents therapeutic equity as the ultimate translational objective: moving from broad heterogeneity toward individualized accessibility, precision support, and ethically responsible care.
For website navigation, these 20 manuscripts can be grouped into five scientific categories:
The FIAP® publication roadmap includes manuscripts that are:
This staged publication strategy reflects the Department’s commitment to responsible scientific development before clinical implementation.
Some manuscripts listed on this page are submitted, under review, in preparation, or planned. Manuscripts that are not yet peer-reviewed should not be interpreted as established clinical recommendations.
The FIAP® ecosystem is being developed through a progressive scientific pathway that includes conceptual clarification, peer-reviewed dissemination, construct operationalization, validation, pilot studies, and responsible implementation.
The 20-manuscript FIAP® roadmap is designed to build a comprehensive scientific foundation for autism precision research, linking biological burden, therapeutic engagement, energetic capacity, adaptive neurodevelopmental windows, neuroplastic potential, digital stratification, ethical responsibility, and therapeutic equity.
Copyright © 2026 ANTIBIOSTRESS CLINICS - All Rights Reserved.
ANTIBIOSTRESS CLINICS / DEPT. OF AUTISM RESEARCH
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.